|
On November 17, 2022, the Centers for Disease Control and Prevention (CDC) released RFA-CE-23-002: Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors.
The purpose of the CDC’s National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) is to provide support for an intensive, supervised (mentored) career development experience in substance use and/or overdose prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent polydrug use and overdose.
Applicants must propose a research project that aims to better understand and identify risk and protective factors related to polydrug initiation, use, escalation, and overdose. This could include, but is not limited to, co-use of opioids, stimulants, and/or cannabis, including co-use with or without the knowledge of the person who is using the drugs. Additionally, research can focus the examination of potential moderators of risk and protective factors for polydrug initiation, use and escalation; and/or can investigate the relationship between polydrug use and overdose.
Research should be conducted among persons experiencing a disproportionate burden of substance use disorders and overdose, which may include but are not limited to those people in certain socio-demographic groups (e.g. non-English speaking populations, tribal populations, rural communities, racial/ethnic minority groups, sexual and gender minority groups), people experiencing certain social determinants of health (e.g., reduced economic stability; limited educational attainment, access or quality; limited healthcare access or quality including those who have been historically underserved or are uninsured; limited access to substance use treatment; limited health literacy; those in geographically underserved areas), or people experiencing certain social or physical health conditions or experiences (e.g., homelessness, a mental health condition, chronic pain, incarceration or recent release from incarceration, a disability, adverse childhood experiences, a history of suicidal ideation or suicide attempt, a history of substance use disorders and/or overdose).
Pre-application teleconference call: December 16, 2022. A pre-application teleconference call will be conducted on December 16, 2022, to address questions from prospective applicants regarding NOFO RFA-CE-23-002. The call will begin at 1pm Eastern Standard Time (EST) and end at 2pm Eastern Standard Time (EST), or sooner if all questions are addressed.
Letter of intent due: December 19, 2022.
Application due: February 9, 2023
| 
